Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Frontiers in Cellular and Infection Microbiology

Cellular and Infection Microbiology

Na Xu¹  Kaikai Yu²  Chengbiao Sun²  Mingxin Dong²  Wensen Liu²  Haotian Yu²  Xuefeng Wang²  Yan Wang²  Jianxu Zhang²  Guorui Li³  Bin Liu⁴ 

[1] Academic Affairs Office, Jilin Medical University, Jilin, Jilin, China;Changchun Veterinary Research Institute, Chinese Academy of Agricultural Science, Changchun, Jilin, China;College of Life Sciences and Food Engineering, Inner Mongolia Minzu University, Tongliao, China;State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China;

关键词: SARS-CoV-2;    COVID-19;    single-chain variable fragment;    bispecific antibody;    Omicron variant;   

DOI  :  10.3389/fcimb.2023.1264974

 received in 2023-07-21, accepted in 2023-08-14,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Yu, Liu, Yu, Sun, Wang, Li, Dong, Wang, Zhang, Xu and Liu